BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 10188934)

  • 1. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
    Coronas V; Krantic S; Jourdan F; Moyse E
    Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP; Howlett AC
    Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach.
    Coronas V; Srivastava LK; Liang JJ; Jourdan F; Moyse E
    J Chem Neuroanat; 1997 May; 12(4):243-57. PubMed ID: 9243344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
    Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
    J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
    Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
    J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine, a dopamine D2 receptor agonist, inhibits adenylyl cyclase activity in rat olfactory epithelium.
    Mania-Farnell BL; Farbman AI; Bruch RC
    Neuroscience; 1993 Nov; 57(1):173-80. PubMed ID: 7904056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
    Izquierdo-Claros RM; Boyano-Adánez MC; Larsson C; Gustavsson L; Arilla E
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):99-107. PubMed ID: 9221906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
    Unterwald EM; Cuntapay M
    Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of opioid and muscarinic receptors stimulates basal adenylyl cyclase but inhibits Ca2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb.
    Olianas MC; Onali P
    J Neurochem; 1994 Jul; 63(1):161-8. PubMed ID: 8207425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats.
    Escanilla O; Yuhas C; Marzan D; Linster C
    Behav Neurosci; 2009 Aug; 123(4):828-33. PubMed ID: 19634942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of muscarinic stimulation of adenylyl cyclase by heparin in rat olfactory bulb.
    Olianas MC; Onali P
    Life Sci; 1997; 61(5):515-22. PubMed ID: 9247321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
    Harvey J; Lacey MG
    J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.